HealthTree Guides

Myeloma Clinical Trial Guide: What Endpoints Mean for You

This guide helps multiple myeloma patients and their loved ones understand clinical trial endpoints, aiding in interpreting clinical data and choosing the right trial. *Medical Review Pending*

1/8/2025

Understanding CLL/SLL Treatments: Fixed and Continuous-Duration Therapy Guide

The purpose of this guide is to assist people with CLL/SLL and their caregivers in understanding fixed and continuous-duration therapies used in CLL/SLL treatment. Fixed-duration therapy involves administering treatment over a set period, then stopping, while continuous-duration therapies are administered indefinitely until the medicine stops working or the patient withdraws due to side effect concerns. Developed independently by HealthTree, this guide has been reviewed by CLL physician Adam Kittai, MD, Icahn School of Medicine at Mount Sinai, people with CLL, and CLL care partners to ensure relevance to you.

1/6/2025

Bispecific Antibodies to Treat Multiple Myeloma: An Educational Guide

Learn about bispecific antibodies designed for multiple myeloma treatment. This guide provides clear information for patients, care partners, and families on how this therapy works, its potential benefits, and what to expect. Empower yourself with knowledge about your treatment options. The guide is reviewed every six months to ensure accuracy and relevance. It has been medically reviewed by Sean Maximillian Taasan, MD, UT Southwestern; Danai Dima, MD, University of Washington School of Medicine

10/18/2024